Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Perry

Showing results (241-250 of 422) with videos related to

Pageof 43
Sort By:
Neuro-Oncology|August 5, 2021
Tumor DNA requirements for accurate epigenetic-based classification of CNS neoplasiaJasper Wu, Rohit Gupta, Jairo Barreto, et al.
Epilepsia|October 13, 2009
Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development)Wendy A Chamberlain, Mark L Cohen, Kymberly A Gyure, et al.
Acta Neuropathologica|May 10, 2016
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryDavid N Louis, Arie Perry, Guido Reifenberger, et al.
Acta Neuropathologica|September 4, 2012
Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entityFausto J Rodriguez, Arie Perry, Marc K Rosenblum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningiomaPang-Hsien Tu, Caterina Giannini, Alexander R Judkins, et al.
World Neurosurgery|December 18, 2017
Presenting Symptoms and Prognostic Factors for Symptomatic Outcomes Following Resection of MeningiomaAshley Wu, Michael A Garcia, Stephen T Magill, et al.
Acta Neuropathologica|February 1, 2023
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomasVivian Tang, Rufei Lu, Kanish Mirchia, et al.
The American Journal of Surgical Pathology|September 17, 2025
Increased SOX10, p16, and Cyclin D1 Immunoreactivity Differentiates MAP Kinase-activated Low-grade Gliomas From Piloid Gliosis: ErratumVivian Tang, Kevin Y Zhang, Kanish Mirchia, et al.
Acta Neuropathologica Communications|September 21, 2018
Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterpartsJulieann Lee, Angelica R Putnam, Samuel H Chesier, et al.
Acta Neuropathologica|September 10, 2014
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomasSriram Venneti, Mariarita Santi, Michelle Madden Felicella, et al.
Pageof 43

Showing results (241-250 of 422) with videos related to

Sort By:
Pageof 43
Neuro-Oncology|August 5, 2021
Tumor DNA requirements for accurate epigenetic-based classification of CNS neoplasiaJasper Wu, Rohit Gupta, Jairo Barreto, et al.
Epilepsia|October 13, 2009
Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development)Wendy A Chamberlain, Mark L Cohen, Kymberly A Gyure, et al.
Acta Neuropathologica|May 10, 2016
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryDavid N Louis, Arie Perry, Guido Reifenberger, et al.
Acta Neuropathologica|September 4, 2012
Disseminated oligodendroglial-like leptomeningeal tumor of childhood: a distinctive clinicopathologic entityFausto J Rodriguez, Arie Perry, Marc K Rosenblum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: a primary low-grade CNS lymphoma that mimics meningiomaPang-Hsien Tu, Caterina Giannini, Alexander R Judkins, et al.
World Neurosurgery|December 18, 2017
Presenting Symptoms and Prognostic Factors for Symptomatic Outcomes Following Resection of MeningiomaAshley Wu, Michael A Garcia, Stephen T Magill, et al.
Acta Neuropathologica|February 1, 2023
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomasVivian Tang, Rufei Lu, Kanish Mirchia, et al.
The American Journal of Surgical Pathology|September 17, 2025
Increased SOX10, p16, and Cyclin D1 Immunoreactivity Differentiates MAP Kinase-activated Low-grade Gliomas From Piloid Gliosis: ErratumVivian Tang, Kevin Y Zhang, Kanish Mirchia, et al.
Acta Neuropathologica Communications|September 21, 2018
Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterpartsJulieann Lee, Angelica R Putnam, Samuel H Chesier, et al.
Acta Neuropathologica|September 10, 2014
A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomasSriram Venneti, Mariarita Santi, Michelle Madden Felicella, et al.
Pageof 43